GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 151 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $14,375,000 | -45.8% | 3,489,055 | -36.8% | 0.71% | -39.7% |
| Q4 2019 | $26,540,000 | -22.4% | 5,517,767 | -2.2% | 1.17% | -27.9% |
| Q3 2019 | $34,197,000 | -6.6% | 5,643,118 | +0.0% | 1.63% | -1.5% |
| Q2 2019 | $36,608,000 | +0.2% | 5,640,748 | +9.5% | 1.65% | +15.9% |
| Q1 2019 | $36,528,000 | +50.1% | 5,152,009 | +2.9% | 1.42% | +25.8% |
| Q4 2018 | $24,339,000 | -13.5% | 5,008,122 | +30.7% | 1.13% | -11.4% |
| Q3 2018 | $28,153,000 | -1.5% | 3,830,399 | -14.5% | 1.28% | -7.0% |
| Q2 2018 | $28,580,000 | +4.2% | 4,479,615 | -11.1% | 1.38% | -7.2% |
| Q1 2018 | $27,424,000 | +31.1% | 5,041,133 | +0.5% | 1.48% | +16.2% |
| Q4 2017 | $20,923,000 | -46.1% | 5,017,483 | +24.4% | 1.28% | -29.8% |
| Q3 2017 | $38,833,000 | -17.6% | 4,032,483 | +1.2% | 1.82% | -20.9% |
| Q2 2017 | $47,147,000 | +15.4% | 3,985,360 | +25.1% | 2.30% | +17.5% |
| Q1 2017 | $40,849,000 | +2.4% | 3,186,382 | -2.3% | 1.96% | -8.0% |
| Q4 2016 | $39,907,000 | -5.6% | 3,260,378 | -9.0% | 2.12% | -4.8% |
| Q3 2016 | $42,265,000 | +19.0% | 3,581,747 | -12.2% | 2.23% | +14.3% |
| Q2 2016 | $35,503,000 | +75.4% | 4,080,759 | +6.2% | 1.95% | +43.6% |
| Q1 2016 | $20,241,000 | -30.7% | 3,840,759 | +2.0% | 1.36% | +29.4% |
| Q4 2015 | $29,218,000 | +39.6% | 3,765,159 | +41.5% | 1.05% | +39.3% |
| Q3 2015 | $20,936,000 | +62.6% | 2,660,195 | +87.1% | 0.75% | +98.9% |
| Q2 2015 | $12,878,000 | +5.8% | 1,421,462 | +51.6% | 0.38% | +15.5% |
| Q1 2015 | $12,169,000 | -4.6% | 937,500 | 0.0% | 0.33% | +2.2% |
| Q4 2014 | $12,759,000 | +60.3% | 937,500 | +5.6% | 0.32% | +53.6% |
| Q3 2014 | $7,961,000 | -33.7% | 887,500 | 0.0% | 0.21% | -41.5% |
| Q2 2014 | $12,008,000 | +38.1% | 887,500 | +1.4% | 0.36% | +64.5% |
| Q1 2014 | $8,698,000 | -15.6% | 875,000 | +12.9% | 0.22% | -18.1% |
| Q4 2013 | $10,300,000 | +86.5% | 775,000 | +70.3% | 0.26% | +63.6% |
| Q3 2013 | $5,524,000 | – | 455,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |